Centre Immunològic de Catalunya SA
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Centre Immunològic de Catalunya SA - overview
Established
1982
Location
Barcelona, -, Spain
Primary Industry
Healthcare
About
Founded in 1982 and based in Barcelona, Spain, Centre Immunològic de Catalunya SA operates as a provider of clinical analysis.
Primary Industry
Healthcare
Sub Industries
Diagnostic, Medical & Imaging Laboratories
Total Amount Raised
Subscriber access only
Centre Immunològic de Catalunya SA - financials
| Fiscal Year Ended | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 |
|---|---|---|---|---|---|
| Revenue (USD) | 6,338,926.1 | 8,314,694 | - | - | - |
| % Revenue Growth (YoY) | - | 31.2% | - | - | - |
| EBITDA (USD) | 682,092.9 | 1,779,182 | - | - | - |
| Operating Income (USD) | 630,095.3 | 1,732,548 | - | - | - |
| Operating Margin | 9.9% | 20.8% | - | - | - |
| % EBITDA Margin | 10.8% | 21.4% | - | - | - |
| NET Income (USD) | 463,048.4 | 1,369,948 | - | - | - |
| % Net Margin | 7.3% | 16.5% | - | - | - |
Centre Immunològic de Catalunya SA - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Centre Immunològic de Catalunya SA | - | ||||||||
| Unspecified Exit | Completed | Centre Immunològic de Catalunya SA | - |
Displaying 1 - 2 of 2
Centre Immunològic de Catalunya SA - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.